wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47777774-8D48D891-C453-43DE-A0BC-AFBF875A2171
Q47777774-8D48D891-C453-43DE-A0BC-AFBF875A2171
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47777774-8D48D891-C453-43DE-A0BC-AFBF875A2171
A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.
P2860
Q47777774-8D48D891-C453-43DE-A0BC-AFBF875A2171
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47777774-8D48D891-C453-43DE-A0BC-AFBF875A2171
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f390839875f61500e0389e06e399eeaeb4d2ae28
P2860
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.